Outcomes of high-grade gastrointestinal graft-versus-host disease posthematopoietic stem cell transplantation in children-Reference-Cited by-同舟云学术

Outcomes of high-grade gastrointestinal graft-versus-host disease posthematopoietic stem cell transplantation in children

Published:2016-11 Issue:44 Volume:95 Page:e5242
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Uygun Vedat,Uygun Dilara F.K.,Daloğlu Hayriye,Öztürkmen Seda Irmak,Karasu Gülsün,Hazar Volkan,Yeşilipek Akif

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation;Hings;Transplantation,1994

2. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation;Van Lint;Blood,1998

3. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate;Nash;Blood,1992

4. Acute graft-versus-host disease in children;Jacobsohn;Bone Marrow Transplant,2008

5. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial;Locatelli;Blood,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases;Frontiers in Pediatrics;2023-05-26

2. The Promise of Precision Nutrition for Modulation of the Gut Microbiota as a Novel Therapeutic Approach to Acute Graft-versus-host Disease;Transplantation;2023-05-16

3. Extended Treatment With Mesenchymal Stromal Cells-Frankfurt am Main in a Pediatric Patient With Steroid-refractory Acute Gastrointestinal Graft-Versus-Host Disease: Case Report and Review of the Literature;Journal of Pediatric Hematology/Oncology;2020-02-28

4. Ruxolitinib salvage therapy is effective for steroid‐refractory graft‐versus‐host disease in children: A single‐center experience;Pediatric Blood & Cancer;2020-01-25